Advanced Search
Contact | Corporate | Help

Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Gemcitabine
  • Drug: Carboplatin
  • Drug: Trastuzumab
Enrollment:
96

Additional information about NCT00193076.


SourceSolution © 2008-2012